These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11449145)

  • 1. [New chemotherapies for colorectal cancer treatment].
    Louvet C
    Gastroenterol Clin Biol; 2001 Apr; 25(4 Suppl):B51-6. PubMed ID: 11449145
    [No Abstract]   [Full Text] [Related]  

  • 2. Combination chemotherapy and colorectal cancer.
    Sumpter K; Cunningham D
    Semin Oncol; 2000 Oct; 27(5 Suppl 10):105-11. PubMed ID: 11049041
    [No Abstract]   [Full Text] [Related]  

  • 3. Current treatment options for advanced colorectal cancer.
    Rougier P; Mitry E
    Semin Oncol; 2000 Oct; 27(5 Suppl 10):30-3. PubMed ID: 11049030
    [No Abstract]   [Full Text] [Related]  

  • 4. A rapid and systematic review of the evidence for the clinical effectiveness and cost-effectiveness of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer.
    Lloyd Jones M; Hummel S; Bansback N; Orr B; Seymour M
    Health Technol Assess; 2001; 5(25):1-128. PubMed ID: 11990245
    [No Abstract]   [Full Text] [Related]  

  • 5. New therapies, new directions: advances in the systemic treatment of metastatic colorectal cancer.
    Holen KD; Saltz LB
    Lancet Oncol; 2001 May; 2(5):290-7. PubMed ID: 11905784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy, which drugs and when.
    Koopman M; Punt CJ
    Eur J Cancer; 2009 Sep; 45 Suppl 1():50-6. PubMed ID: 19775604
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemotherapy of metastatic colorectal cancer: fluorouracil plus folinic acid and irinotecan or oxaliplatin.
    Prescrire Int; 2005 Dec; 14(80):230-3. PubMed ID: 16400749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review article: colorectal cancer chemotherapy.
    Gill S; Thomas RR; Goldberg RM
    Aliment Pharmacol Ther; 2003 Oct; 18(7):683-92. PubMed ID: 14510741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chemotherapy for colorectal cancers].
    Lièvre A; Mitry E
    J Chir (Paris); 2003 Feb; 140(1):52-5. PubMed ID: 12709655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colon cancer: new drug options improve on 5-FU.
    McCann J
    J Natl Cancer Inst; 1998 Jul; 90(13):963-5. PubMed ID: 9665142
    [No Abstract]   [Full Text] [Related]  

  • 11. [A review of FOLFOXIRI chemotherapy for the 1st line treatment of metastatic colorectal cancer].
    Kawakami H; Satoh T; Nakagawa K
    Nihon Rinsho; 2011 Apr; 69 Suppl 3():439-45. PubMed ID: 22214001
    [No Abstract]   [Full Text] [Related]  

  • 12. The changing face of chemotherapy in colorectal cancer.
    Waters J; Cunningham D
    Br J Cancer; 2001 Jan; 84(1):1-7. PubMed ID: 11139304
    [No Abstract]   [Full Text] [Related]  

  • 13. [Safety and efficacy of FOLFOX and FOLFIRI in elderly patients with colorectal cancer].
    Mishima H; Ikenaga M; Yasui M
    Nihon Rinsho; 2011 Apr; 69 Suppl 3():554-8. PubMed ID: 22214022
    [No Abstract]   [Full Text] [Related]  

  • 14. [Chemotherapy for advanced colorectal cancer].
    Munakata M; Sakata Y
    Nihon Rinsho; 2011 Apr; 69 Suppl 3():30-6. PubMed ID: 22213927
    [No Abstract]   [Full Text] [Related]  

  • 15. Second-line therapy in colorectal cancer.
    Berlin J
    Oncology (Williston Park); 2000 Dec; 14(12 Suppl 11):21-6. PubMed ID: 11204658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequencing therapies: the role of targeted agents in metastatic colorectal cancer.
    Oestreicher P
    ONS Connect; 2007; 22(8 Suppl):37-8. PubMed ID: 17824557
    [No Abstract]   [Full Text] [Related]  

  • 17. Should FOLFOXIRI plus bevacizumab Be the standard first-line therapy in metastatic colorectal cancer?
    Nipp RD; Ryan DP
    Oncologist; 2015 Mar; 20(3):236-8. PubMed ID: 25660156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved first-line chemotherapy: a better chance for surgery?
    Tejpar S; Van Cutsem E; Adam R
    Lancet Oncol; 2010 Jan; 11(1):4-5. PubMed ID: 19942480
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of chemotherapy for advanced colorectal cancer: new opportunities.
    Bleiberg H
    Semin Oncol; 1996 Feb; 23(1 Suppl 3):42-50. PubMed ID: 8633253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxaliplatin in colorectal cancer: an overview.
    Armand JP; Boige V; Raymond E; Fizazi K; Faivre S; Ducreux M
    Semin Oncol; 2000 Oct; 27(5 Suppl 10):96-104. PubMed ID: 11049040
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.